接种疫苗
医学
无症状的
2019年冠状病毒病(COVID-19)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
危险系数
免疫学
内科学
置信区间
疾病
传染病(医学专业)
作者
Taoyuan Li,Shaorong Wu,Jiaxiong Tan,Zhengyi Huang,Lijun Li,Wenzhi Luo,Yayun Wu,Jun Lyu,Xujing Liang
出处
期刊:Viral Immunology
[Mary Ann Liebert]
日期:2023-09-05
卷期号:36 (8): 544-549
标识
DOI:10.1089/vim.2023.0050
摘要
Omicron variants have become the dominant SARS-CoV-2 variants due to their increased transmissibility and immune-escape ability. An outbreak of the Omicron variant BA.5.1.3 occurred in August 2022 in Sanya, China. Studying Omicron variants can promote the understanding of them and further contribute to managing the SARS-CoV-2 prevalence. This retrospective study analyzed the data of 258 patients with asymptomatic or mild SARS-CoV-2 admitted to the First Cabin Hospital of Sanya, China, between August 14 and September 4, 2022. The 258 patients comprised 128 males and 130 females with a mean age of 36.6 years and mean length of medical observation (LMO) of 10.1 days. Multiple linear regression analysis indicated that LMO was positively and negatively associated with age (p = 0.036) and vaccination status (p = 0.004), respectively. A Cox proportional-hazards model revealed that age (hazard ratio [HR] = 0.99, p = 0.029) and vaccination (HR = 1.23, p = 0.023) were risk and protective factors for LMO, respectively. Causal mediation analysis indicated that vaccination suppressed the effect of prolonging LMO caused by increasing age. Recovery times became longer with increasing age, which could be counterbalanced by vaccination. The present results indicate that vaccination interventions, even those developed through inactivated approaches, can still provide protection against Omicron variants.
科研通智能强力驱动
Strongly Powered by AbleSci AI